Page last updated: 2024-10-28

hexamethonium and Peripheral Arterial Disease

hexamethonium has been researched along with Peripheral Arterial Disease in 1 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Peripheral Arterial Disease: Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
TRENCH, NF1
MONFORT, J1

Other Studies

1 other study available for hexamethonium and Peripheral Arterial Disease

ArticleYear
[Use of hexamethonium as test for indication for sympathectomy in peripheral arteriopathy of the lower extremities].
    Revista paulista de medicina, 1953, Volume: 42, Issue:4

    Topics: Hexamethonium; Lower Extremity; Muscle Relaxants, Central; Peripheral Arterial Disease; Peripheral V

1953
chemdatabank.com